Zoledronic acid is effective and safe in migratory osteoporosis

Rheumatology (Oxford). 2020 Feb 1;59(2):439-440. doi: 10.1093/rheumatology/kez345.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Bone Density Conservation Agents / adverse effects
  • Bone Density Conservation Agents / therapeutic use*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Osteoporosis / drug therapy*
  • Treatment Outcome
  • Zoledronic Acid / adverse effects
  • Zoledronic Acid / therapeutic use*

Substances

  • Bone Density Conservation Agents
  • Zoledronic Acid